Fred Salchli - Profile and Investment Details

Investor Profile

Fred Salchli is a Venture Capital based in Chicago, Illinois, United States with a diverse investment portfolio that includes companies such as Nuo Therapeutics, X4 Pharmaceuticals, Ocata Therapeutics, Lightwave Logic, Aileron Therapeutics, Raptor Pharmaceuticals, Elite Pharmaceuticals, Onconova Therapeutics, Phio Pharmaceuticals, InVivo Therapeutics, Plandai Biotechnology, Onstream Media, rMark Bio, Emmaus Medical. Over time, Fred Salchli has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Fred Salchli is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Women Founded, Enterprise Software, Life Science, Artificial Intelligence (AI), Biotech, Cloud Computing, Medical Device, Software, Manufacturing, Healthcare, Biotechnology, Hispanic / Latinx Founded, Clean Technology, Big Data Analytics, Clinical Trials, Investment Banking, Hardware, Medical, Big Data, Therapeutics, Pharmaceuticals, Business Intelligence, Collaboration, Biopharma may find it worthwhile to explore potential connections with Fred Salchli, as their portfolio suggests a familiarity and interest in this area.

Understanding Fred Salchli’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.